Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Valenti

Showing results (181-190 of 439) with videos related to

Pageof 44
Sort By:
Alcohol and Alcoholism (Oxford, Oxfordshire)|June 23, 2004
Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patientsLuca Valenti, Tullia De Feo, Anna Ludovica Fracanzani, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 15, 2013
Triple therapy with first-generation protease inhibitors for patients with genotype 1 chronic hepatitis C: recommendations of the Italian association for the study of the liver (AISF), Barbara Coco, Paolo Caraceni, et al.
Alimentary Pharmacology & Therapeutics|March 22, 2023
Adverse effect of PNPLA3 p.I148M genetic variant on kidney function in middle-aged individuals with metabolic dysfunctionAlessandro Mantovani, Serena Pelusi, Sara Margarita, et al.
Plos One|November 13, 2012
The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver diseaseLuca Valenti, Raffaela Rametta, Paola Dongiovanni, et al.
International Journal of Biological Sciences|June 16, 2018
FGF23 and Fetuin-A Interaction in the Liver and in the CirculationDeborah Mattinzoli, Masami Ikehata, Koji Tsugawa, et al.
Metabolism: Clinical and Experimental|October 2, 2024
Comparative efficacy of THR-β agonists, FGF-21 analogues, GLP-1R agonists, GLP-1-based polyagonists, and Pan-PPAR agonists for MASLD: A systematic review and network meta-analysisRu-Tao Lin, Qin-Mei Sun, Xin Xin, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 14, 2011
LPIN1 rs13412852 polymorphism in pediatric nonalcoholic fatty liver diseaseLuca Valenti, Benedetta Maria Motta, Anna Alisi, et al.
Plos One|September 21, 2016
Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver DiseaseSerena Pelusi, Salvatore Petta, Chiara Rosso, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 23, 2009
HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patientsLuca Valenti, Domenico Girelli, Giovanni Francesco Valenti, et al.
The American Journal of Medicine|January 12, 2008
Carotid artery intima-media thickness in nonalcoholic fatty liver diseaseAnna Ludovica Fracanzani, Larry Burdick, Sara Raselli, et al.
Pageof 44

Showing results (181-190 of 439) with videos related to

Sort By:
Pageof 44
Alcohol and Alcoholism (Oxford, Oxfordshire)|June 23, 2004
Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patientsLuca Valenti, Tullia De Feo, Anna Ludovica Fracanzani, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 15, 2013
Triple therapy with first-generation protease inhibitors for patients with genotype 1 chronic hepatitis C: recommendations of the Italian association for the study of the liver (AISF), Barbara Coco, Paolo Caraceni, et al.
Alimentary Pharmacology & Therapeutics|March 22, 2023
Adverse effect of PNPLA3 p.I148M genetic variant on kidney function in middle-aged individuals with metabolic dysfunctionAlessandro Mantovani, Serena Pelusi, Sara Margarita, et al.
Plos One|November 13, 2012
The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver diseaseLuca Valenti, Raffaela Rametta, Paola Dongiovanni, et al.
International Journal of Biological Sciences|June 16, 2018
FGF23 and Fetuin-A Interaction in the Liver and in the CirculationDeborah Mattinzoli, Masami Ikehata, Koji Tsugawa, et al.
Metabolism: Clinical and Experimental|October 2, 2024
Comparative efficacy of THR-β agonists, FGF-21 analogues, GLP-1R agonists, GLP-1-based polyagonists, and Pan-PPAR agonists for MASLD: A systematic review and network meta-analysisRu-Tao Lin, Qin-Mei Sun, Xin Xin, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 14, 2011
LPIN1 rs13412852 polymorphism in pediatric nonalcoholic fatty liver diseaseLuca Valenti, Benedetta Maria Motta, Anna Alisi, et al.
Plos One|September 21, 2016
Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver DiseaseSerena Pelusi, Salvatore Petta, Chiara Rosso, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 23, 2009
HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patientsLuca Valenti, Domenico Girelli, Giovanni Francesco Valenti, et al.
The American Journal of Medicine|January 12, 2008
Carotid artery intima-media thickness in nonalcoholic fatty liver diseaseAnna Ludovica Fracanzani, Larry Burdick, Sara Raselli, et al.
Pageof 44